KD-PÜR
LIVE

Serial Number

79294557

Owner

K.D. PHARMA BEXBACH GMBH

Attorney

Christian Wolff

Filing Date

Jul 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KD-PÜR Trademark

Serial Number: 79294557 • Registration: 6674408

KD-PÜR is a trademark filed by K.D. PHARMA BEXBACH GMBH on July 22, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

K.D. PHARMA BEXBACH GMBH (11 trademarks)

AM KRAFTWERK 6
BEXBACH 66450 , DE

Entity Type: 16

Trademark Details

Filing Date

July 22, 2020

Registration Date

March 22, 2022

Published for Opposition

January 4, 2022

Goods & Services

Contract manufacturing for others of pharmaceutical products, dietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oils, powders and capsules

Pharmaceutical and veterinary products, namely, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, and chemical reagents for medical or veterinary purposes; sanitary preparations for medical use; dietetic foodstuffs and preparations for medical or veterinary purposes, namely, dietetic foods and beverages adapted for medical use, dietetic foods adapted for veterinary use, dietetic beverages adapted for veterinary use, and dietetic preparations adapted for medical purposes; dietary supplements for humans and animals; pharmaceutical products in the nature of oils, powders and capsules containing omega-3-extracts for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutritional supplements; dietetic preparations adapted for medical purposes containing omega-3-extracts and in the form of oils, powders and capsules containing omega-3-extracts

Scientific and technological services, namely, pharmaceutical research and development, pharmaceutical products development, testing of pharmaceuticals, development of pharmaceutical preparations and medicines, scientific research in the field of pharmaceuticals, pharmaceutical research services, laboratory research services relating to pharmaceuticals, scientific analysis in the field of nutritional supplements; scientific research and development in the field of lipid extraction from natural resources; scientific laboratory services; chemical laboratories; scientific and industrial research for others relating to the manufacture of pharmaceutical products, dietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oils, powders and capsules

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 21, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 2, 2022 OPNR
NOTIFICATION PROCESSED BY IB
Jan 22, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 15, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 25, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 25, 2021 ERFR
DATA MODIFICATION COMPLETED
Jun 1, 2021 DMCC
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 1, 2021 GNFN
FINAL REFUSAL E-MAILED
Jun 1, 2021 GNFR
FINAL REFUSAL WRITTEN
Jun 1, 2021 CNFR
ASSIGNED TO LIE
Jun 1, 2021 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 13, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 25, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 3, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2020 REPR